| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/23/2000 | CN1245168A Amino quinoline derivatives |
| 02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
| 02/23/2000 | CN1049670C Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and preparing process |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/22/2000 | US6028182 Methylphosphonic acid esters, processes for their preparation, and their use |
| 02/22/2000 | US6028181 6-0-Substituted antibacterial erythromycin ketolides and methods of making |
| 02/22/2000 | US6028169 Chemokine β-6 antagonists |
| 02/22/2000 | US6028104 Use of peroxygen compounds in the control of hairy wart disease |
| 02/22/2000 | US6028097 Method of immunosuppression |
| 02/22/2000 | US6028081 Substituted quinolone derivatives and pharmaceuticals containing the same |
| 02/22/2000 | US6028074 Pyrazolo[3,4-d]pyrimidineone compounds |
| 02/22/2000 | US6028058 Methods and compositions for regulating nuclear trafficking of proteins |
| 02/22/2000 | US6028051 Administering single dose of lysostaphin analogue and lysostaphin for treating endocarditis, bacterimia, kidney infection, lung infection, skin infection, bone infection, burn wound infections, infection of prosthetic devices |
| 02/22/2000 | US6028049 Compositions comprising the Tbp2 subunit of the transferrin receptor of Neisseria meningitidis |
| 02/22/2000 | US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders |
| 02/22/2000 | US6027736 An avian vaccine for immunizing, esp. poultry, comprising four siderophore receptor, outer-membrane proteins of enterobacter and a non-iron-regulated outer membrane protein from enterobacter/pasteurella; broad-basedcross-protection |
| 02/22/2000 | US6027734 To provide protection against pneumococcal colonization and systemic infection, intranasally administering a composition consisting essentially of pneumococcal surface protein a or a fragment containing a protection-eliciting epitope |
| 02/22/2000 | US6027733 Method for generating saccharide fragments |
| 02/22/2000 | US6027731 Pertussis toxin induced lymphocytosis |
| 02/22/2000 | US6027730 Herpes simplex vaccine comprising HSV glycoprotein GD and 3 deacylated monophosphoryl lipid A |
| 02/22/2000 | US6027716 Comprising an essential oil of cinnamon oil and herbal extract of a mixture of plantago, hypericum, echinacea and propolis, bactericides; fungicides; viricides; parasiticides; oral hygiene; mucosal organs |
| 02/22/2000 | CA2208707C Novel aminooligosaccharide derivative and process for preparing the same |
| 02/22/2000 | CA2170607C Difluoro statone antiviral analogs |
| 02/22/2000 | CA2137395C 9a-n-(n'-carbamoyl) and 9a-n-(n' - thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin a |
| 02/22/2000 | CA2081356C Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents |
| 02/22/2000 | CA1340910C Fibronectin binding protein |
| 02/22/2000 | CA1340909C Purine derivatives and use thereof in therapy |
| 02/17/2000 | WO2000008197A1 Method for the production of an antibiotic agent |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008182A1 Herpesvirus preparations and their uses |
| 02/17/2000 | WO2000008167A1 Trimer of hiv env gene expression product |
| 02/17/2000 | WO2000008158A2 Molecules designated ldcam |
| 02/17/2000 | WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008051A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | WO2000008046A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 02/17/2000 | WO2000008044A1 2'-o-aminoethyloxyethyl-modified oligonucleotides |
| 02/17/2000 | WO2000008043A2 Prevention and treatment of viral disease |
| 02/17/2000 | WO2000008007A2 Cyclopentabenzofuran derivatives and their use |
| 02/17/2000 | WO2000007980A1 Amide derivatives which are useful as cytokine inhibitors |
| 02/17/2000 | WO2000007974A1 2-fluoro mutilin derivatives |
| 02/17/2000 | WO2000007631A1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 02/17/2000 | WO2000007623A1 Combined vaccine for immunoprophylaxis against viral hepatitis b and d, tetanus, diphtheria and pertussis |
| 02/17/2000 | WO2000007622A1 Attenuated poliovirus vaccine |
| 02/17/2000 | WO2000007618A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 02/17/2000 | WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same |
| 02/17/2000 | WO2000007608A1 COMPOSITION AND METHOD OF TREATING DISEASE WITH EXTRACT OF $i(MUSACEAS) |
| 02/17/2000 | WO2000007591A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007590A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000000223A3 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 02/17/2000 | WO1999065942A8 Cyclic somatostatin analogs |
| 02/17/2000 | WO1999063931A3 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor |
| 02/17/2000 | WO1999062534B1 IL-6/sIL-6R COMPLEX FOR PROMOTION OF LIVER FUNCTIONS |
| 02/17/2000 | WO1999061613A3 Interference with viral ires-mediated translation by a small yeast rna reveals critical rna-protein interactions |
| 02/17/2000 | WO1999051604A3 Process for the production of purine derivatives |
| 02/17/2000 | WO1999020261A3 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 02/17/2000 | WO1998029442A9 ANNEXIN V-BINDING POLYPEPTIDES DERIVED FROM HBsAg AND THEIR USES |
| 02/17/2000 | CA2343163A1 Composition and method of treating disease with extract of musaceas |
| 02/17/2000 | CA2339638A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
| 02/17/2000 | CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | CA2339178A1 2'-o-aminoethyloxyethyl-modified oligonucleotides |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2338983A1 Prevention and treatment of viral disease |
| 02/17/2000 | CA2338855A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338727A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/17/2000 | CA2338020A1 Trimer of hiv env gene expression product |
| 02/17/2000 | CA2337968A1 Herpesvirus preparations and their uses |
| 02/17/2000 | CA2336523A1 Immunological herpes simplex virus antigens and methods for use thereof |
| 02/17/2000 | CA2280449A1 Stabilized protein compositions |
| 02/16/2000 | EP0979867A2 Immunodominant human T-cell epitopes of hepatitis C virus |
| 02/16/2000 | EP0979286A2 Combinatorial polyketide libraries produced using a modular pks gene cluster as scaffold |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979244A1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same |
| 02/16/2000 | EP0979230A1 6,7-disubstituted-4-aminopyrido[2,3-d]pyrimidine compounds |
| 02/16/2000 | EP0979229A1 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors |
| 02/16/2000 | EP0979101A1 Recombinant canine adenovirus (cav) containing exogenous dna |
| 02/16/2000 | EP0979100A1 ANTI-$i(HELICOBACTER) VACCINE COMPOSITION COMPRISING A TH1 ADJUVANT |
| 02/16/2000 | EP0979082A1 Antiviral combinations containing the carbocyclic nucleoside 1592u89 |
| 02/16/2000 | EP0979080A1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 02/16/2000 | EP0979078A1 Substituted bis-acridines and related compounds as ccr5 receptor ligands, anti-inflammatory agents and anti-viral agents |
| 02/16/2000 | EP0561885B1 Subunit papillomavirus vaccine |
| 02/16/2000 | CN1244871A H. pylori antigens |
| 02/16/2000 | CN1244869A Crystal form O of clarithromycin |
| 02/16/2000 | CN1244868A New carbapenem derivatives |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244860A Cyclic imines as pesticides |
| 02/16/2000 | CN1244802A Reductive alkylation of glycopeptide antibiotics |
| 02/16/2000 | CN1244799A L-beta-dioxolane uridine analogs and method for treating and preventing virus infections |
| 02/16/2000 | CN1244796A Pellets having a core coated with an antifungal and a polymer |
| 02/16/2000 | CN1244772A Targeted cytotoxic cell |
| 02/16/2000 | CN1244769A Antimicrobial proteins |
| 02/16/2000 | CN1244532A 3,6-aldehyde acetal and enol ether large ring lactone vitamine |
| 02/16/2000 | CN1244422A Pain relieving ointment and its preparation |
| 02/16/2000 | CN1049357C Treatment of human viral infection by ds RNA combined with viral inhibitors |
| 02/15/2000 | US6025487 Reacting 2-(4-azetidin-2-one)-cyclohexanone derivatives with sterically hindered organic base in presence of lewis acid |
| 02/15/2000 | US6025484 Protein D--an IgD-binding protein ofhaemophilus influenzae |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025446 Wound healing agent with sensitivity; equilibrium controlled diffusion |
| 02/15/2000 | US6025398 Benzamidoxime prodrugs as antipneumocystic agents |